KR102660060B1 - Functional porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, Glehnia littoralis and yam - Google Patents
Functional porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, Glehnia littoralis and yam Download PDFInfo
- Publication number
- KR102660060B1 KR102660060B1 KR1020210050150A KR20210050150A KR102660060B1 KR 102660060 B1 KR102660060 B1 KR 102660060B1 KR 1020210050150 A KR1020210050150 A KR 1020210050150A KR 20210050150 A KR20210050150 A KR 20210050150A KR 102660060 B1 KR102660060 B1 KR 102660060B1
- Authority
- KR
- South Korea
- Prior art keywords
- porridge
- yam
- haebangpung
- hemp
- functional
- Prior art date
Links
- 235000021395 porridge Nutrition 0.000 title claims abstract description 160
- 244000146486 Glehnia littoralis Species 0.000 title claims abstract description 8
- 235000004036 Glehnia littoralis Nutrition 0.000 title claims abstract description 8
- 230000002785 anti-thrombosis Effects 0.000 title abstract description 13
- 230000000694 effects Effects 0.000 title description 13
- 230000003064 anti-oxidating effect Effects 0.000 title 1
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 84
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims abstract description 83
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims abstract description 83
- 235000009120 camo Nutrition 0.000 claims abstract description 83
- 235000005607 chanvre indien Nutrition 0.000 claims abstract description 83
- 239000011487 hemp Substances 0.000 claims abstract description 83
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 33
- 235000009566 rice Nutrition 0.000 claims abstract description 33
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 24
- 230000003178 anti-diabetic effect Effects 0.000 claims abstract description 17
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000003472 antidiabetic agent Substances 0.000 claims abstract description 12
- 240000007594 Oryza sativa Species 0.000 claims description 29
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 10
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 239000003146 anticoagulant agent Substances 0.000 abstract description 5
- 238000003860 storage Methods 0.000 abstract description 4
- 230000001055 chewing effect Effects 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 241000209094 Oryza Species 0.000 abstract 4
- 235000004879 dioscorea Nutrition 0.000 description 60
- 235000002723 Dioscorea alata Nutrition 0.000 description 59
- 235000007056 Dioscorea composita Nutrition 0.000 description 59
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 59
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 59
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 59
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 59
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 59
- 244000281702 Dioscorea villosa Species 0.000 description 59
- 238000004519 manufacturing process Methods 0.000 description 48
- 239000000284 extract Substances 0.000 description 29
- 235000013305 food Nutrition 0.000 description 27
- 239000000523 sample Substances 0.000 description 21
- 239000000203 mixture Substances 0.000 description 20
- 239000000843 powder Substances 0.000 description 20
- 230000002401 inhibitory effect Effects 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 17
- 238000002835 absorbance Methods 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 235000006708 antioxidants Nutrition 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 9
- -1 amine salt Chemical class 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000002000 scavenging effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 description 8
- 230000015271 coagulation Effects 0.000 description 7
- 238000005345 coagulation Methods 0.000 description 7
- 239000000469 ethanolic extract Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000002949 hemolytic effect Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 108090000190 Thrombin Proteins 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 229960004072 thrombin Drugs 0.000 description 6
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 5
- 235000017491 Bambusa tulda Nutrition 0.000 description 5
- 241001330002 Bambuseae Species 0.000 description 5
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 5
- 108010094028 Prothrombin Proteins 0.000 description 5
- 102100027378 Prothrombin Human genes 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 5
- 239000011425 bamboo Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 229940039716 prothrombin Drugs 0.000 description 5
- 240000000249 Morus alba Species 0.000 description 4
- 235000008708 Morus alba Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 239000010460 hemp oil Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- 235000008935 nutritious Nutrition 0.000 description 4
- 229940124595 oriental medicine Drugs 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000021067 refined food Nutrition 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 244000289527 Cordyline terminalis Species 0.000 description 3
- 235000009091 Cordyline terminalis Nutrition 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 3
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 108010028144 alpha-Glucosidases Proteins 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 235000013527 bean curd Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000012041 food component Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 235000001270 Allium sibiricum Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 240000004244 Cucurbita moschata Species 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 229940019700 blood coagulation factors Drugs 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000015136 pumpkin Nutrition 0.000 description 2
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 101800002638 Alpha-amanitin Proteins 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 244000289276 Bambusa oldhamii Species 0.000 description 1
- 235000004270 Bambusa oldhamii Nutrition 0.000 description 1
- YRDLZUUWYLCHDP-UHFFFAOYSA-N COC(C1=C(C(OC)=C2CCC(O)=O)OC=C1)=C2O Chemical compound COC(C1=C(C(OC)=C2CCC(O)=O)OC=C1)=C2O YRDLZUUWYLCHDP-UHFFFAOYSA-N 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- GDKGOXUWEBGZBY-WQTURIIHSA-N Cryptogenin Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(=O)[C@H]([C@H](C)C(=O)CC[C@H](CO)C)[C@@]1(C)CC2 GDKGOXUWEBGZBY-WQTURIIHSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- FWCXELAAYFYCSR-UHFFFAOYSA-N Episamogenin Natural products CC1C(C2(CCC3C4(C)CC(O)C(O)CC4CCC3C2C2)C)C2OC11CCC(C)CO1 FWCXELAAYFYCSR-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 240000000797 Hibiscus cannabinus Species 0.000 description 1
- 235000008586 Hovenia Nutrition 0.000 description 1
- 241000405398 Hovenia Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- RTATXGUCZHCSNG-TYSPDFDMSA-N Kaempferol-3-O-rutinoside Natural products OC1[C@H](O)[C@@H](O)C(C)O[C@H]1OCC1[C@@H](O)[C@@H](O)C(O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-TYSPDFDMSA-N 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- GDKGOXUWEBGZBY-UHFFFAOYSA-N Kryptogenin Natural products C1C=C2CC(O)CCC2(C)C2C1C1CC(=O)C(C(C)C(=O)CCC(CO)C)C1(C)CC2 GDKGOXUWEBGZBY-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000229182 Ledebouriella seseloides Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 244000021685 Mesembryanthemum crystallinum Species 0.000 description 1
- 235000009071 Mesembryanthemum crystallinum Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 241001095209 Monascus sp. (in: Fungi) Species 0.000 description 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 description 1
- RTATXGUCZHCSNG-QHWHWDPRSA-N Nicotiflorin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-QHWHWDPRSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010053141 Oligodipsia Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241000244268 Peucedanum japonicum Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 241001274961 Rubus repens Species 0.000 description 1
- RXGJTYFDKOHJHK-UHFFFAOYSA-N S-deoxo-amaninamide Natural products CCC(C)C1NC(=O)CNC(=O)C2Cc3c(SCC(NC(=O)CNC1=O)C(=O)NC(CC(=O)N)C(=O)N4CC(O)CC4C(=O)NC(C(C)C(O)CO)C(=O)N2)[nH]c5ccccc35 RXGJTYFDKOHJHK-UHFFFAOYSA-N 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000004007 alpha amanitin Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- CIORWBWIBBPXCG-SXZCQOKQSA-N alpha-amanitin Chemical compound O=C1N[C@@H](CC(N)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N[C@@H](C2)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@H]1C[S@@](=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-SXZCQOKQSA-N 0.000 description 1
- CIORWBWIBBPXCG-UHFFFAOYSA-N alpha-amanitin Natural products O=C1NC(CC(N)=O)C(=O)N2CC(O)CC2C(=O)NC(C(C)C(O)CO)C(=O)NC(C2)C(=O)NCC(=O)NC(C(C)CC)C(=O)NCC(=O)NC1CS(=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 231100000313 clinical toxicology Toxicity 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 230000014508 negative regulation of coagulation Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003959 neuroinflammation Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- RTATXGUCZHCSNG-ZFDPGQBLSA-N nicotiflorin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O)c3)C2=O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 RTATXGUCZHCSNG-ZFDPGQBLSA-N 0.000 description 1
- RTATXGUCZHCSNG-UHFFFAOYSA-N nicotiflorine Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- CMFNMSMUKZHDEY-UHFFFAOYSA-M peroxynitrite Chemical compound [O-]ON=O CMFNMSMUKZHDEY-UHFFFAOYSA-M 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- RAGZUCNPTLULOL-UHFFFAOYSA-N trans-3-feruloylquinic acid Natural products C1=C(O)C(OC)=CC(C=CC(=O)OC2C(C(O)CC(O)(C2)C(O)=O)O)=C1 RAGZUCNPTLULOL-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- FWCXELAAYFYCSR-JSEAXMQNSA-N yonogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@H](O)[C@@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 FWCXELAAYFYCSR-JSEAXMQNSA-N 0.000 description 1
- 229960005502 α-amanitin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 헴프씨드(Hempseed), 해방풍(Glehnia littoralis) 및 마(yam)를 포함하는, 항산화, 항당뇨 및 항혈전 활성이 우수한 기능성 죽에 관한 것으로서, 보다 구체적으로는, 멥쌀죽을 베이스로 하고, 상기 멥쌀죽에 헴프씨드, 해방풍 및 마를 더 포함시킴으로서 항산화, 항당뇨 및 항혈전의 기능성을 갖는 쌀죽에 관한 것이다. 본 발명의 헴프씨드, 해방풍 및 마를 포함하는 기능성 죽은 관능성, 영양성, 저작성이 우수하며, 통상의 쌀죽에 비해 우수한 항산화, 항당뇨 및 항혈전 활성을 나타낸다. 또한, 상기 기능성 죽은 동결건조되어 간편하게 물만 부어 죽으로 만들어 간편성과 저장성이 우수하며, 헴프씨드 특유의 고소함과 해방풍과 마의 관능성을 기대할 수 있다.The present invention relates to a functional porridge containing hempseed, Glehnia littoralis and yam and having excellent antioxidant, anti-diabetic and anti-thrombotic activities. More specifically, it is based on non-glutinous rice porridge, It relates to rice porridge with antioxidant, anti-diabetic and anti-thrombotic functionality by further including hemp seeds, haebangpung and yam in the non-glutinous rice porridge. The functional porridge containing hemp seeds, Haebangpung and yam of the present invention has excellent organoleptic properties, nutritional properties and chewing properties, and exhibits excellent antioxidant, anti-diabetic and anti-thrombotic activities compared to conventional rice porridge. In addition, the functional porridge is freeze-dried and can be easily made into porridge by simply pouring water, so it has excellent convenience and storage, and you can expect the unique nutty flavor and libation of hemp seeds and the sensuality of yam.
Description
본 발명은 헴프씨드(Hempseed), 해방풍(Glehnia littoralis) 및 마(yam)를 포함하는, 항산화, 항당뇨 및 항혈전 활성이 우수한 기능성 죽에 관한 것으로서, 보다 구체적으로는, 멥쌀죽을 베이스로 하고, 상기 멥쌀죽에 헴프씨드, 해방풍 및 마를 더 포함시킴으로서 항산화, 항당뇨 및 항혈전의 기능성을 갖는 쌀죽에 관한 것이다.The present invention relates to a functional porridge containing hempseed, Glehnia littoralis and yam and having excellent antioxidant, anti-diabetic and anti-thrombotic activities. More specifically, it is based on non-glutinous rice porridge, It relates to rice porridge with antioxidant, anti-diabetic and anti-thrombotic functionality by further including hemp seeds, haebangpung and yam in the non-glutinous rice porridge.
죽은 쌀, 보리 등의 곡류에 물을 많이 부어 오랫동안 가열하여 곡류 알갱이의 녹말이 호화되어 풀의 상태까지 무르게 만든 유동 식품이다. 간편성과 영양성, 소화 흡수율이 우수하여, 노인식, 유아식, 환자식 등으로 이용되어 왔다. 과거에는 식량이 부족할 때에 소량의 곡물로 죽을 쑤어 많은 사람이 먹기도 하였으나, 최근에는 건강 증진을 위해 다양한 건강 식재료를 첨가한 건강 기능성 죽과 고령친화 식품들이 개발되고 있다. Porridge is a liquid food made by pouring a lot of water into grains such as rice and barley and heating them for a long time to gelatinize the starch in the grains and soften them to the state of paste. Because of its simplicity, nutritional value, and excellent digestion and absorption rate, it has been used as food for the elderly, infants, and patients. In the past, when food was scarce, many people made porridge with a small amount of grains and ate it, but recently, healthy functional porridges and senior-friendly foods with various healthy ingredients are being developed to improve health.
한편, 헴프씨드(Hempseed, Seed of Cannabis sativa L.)는 삼과의 한해살이풀인 대마의 씨앗으로서 껍질에 있는 환각성분인 THC(Tetrahydrocanabinol)를 제거하여 식용 가능한 상태인 것을 말한다. 원산지는 중앙아시아이며, 현재는 전 세계 다양한 지역에서 재배하고 있다. 헴프씨드는 고소하면서도 부드러운 식감을 가지고 있어 여타의 견과류와 유사한 맛을 나타내며, 단백질, 필수 아미노산 및 미네랄 함량이 높아 영양적으로 우수하며, 지방 함량이 높아(25~35%) 압착 추출하여 식용유로도 이용하고 있다. 또한, 헴프씨드의 오일은 알파 리놀렌산(Alpha-Linolenic Acid; ALA)과 감마 리놀렌산(gamma-linolenic Acid; GLA) 등의 다가 불포화 지방산(Polyunsaturated fatty acid) 등이 풍부하여, 콜레스테롤 감소, 혈관염증 완화, 피부 질환, 아토피 감소 효과가 우수하다고 알려져 있다. 한방에서는 마자인으로 부르며, 난치성 변비, 소갈증, 각종 통증질환, 월경불순, 피부질환 및 이질 등에 사용하며, 최근에는 신경염증 억제 및 신경세포 보호 활성 등이 잘 알려져 있다.Meanwhile, hempseed (Seed of Cannabis sativa L.) is the seed of cannabis, an annual plant of the cedar family, and is edible by removing the hallucinogenic ingredient THC (Tetrahydrocanabinol) from the peel. Its origin is Central Asia, and it is currently cultivated in various regions around the world. Hemp seeds have a nutty yet soft texture and taste similar to other nuts. They are nutritious due to their high protein, essential amino acid, and mineral contents. They also have a high fat content (25-35%) and can be used as cooking oil by pressing and extracting them. I am using it. In addition, hemp seed oil is rich in polyunsaturated fatty acids such as alpha-linolenic acid (ALA) and gamma-linolenic acid (GLA), which help reduce cholesterol, alleviate vascular inflammation, It is known to be effective in reducing skin diseases and atopy. In oriental medicine, it is called Mazain and is used for intractable constipation, hypodipsia, various pain diseases, menstrual irregularities, skin diseases, and dysentery. Recently, it is well known for its activity in suppressing neuroinflammation and protecting nerve cells.
헴프씨드와 관련된 연구로는, 지방산 분석(Koh DH, 1990, Korean J Food Nutr 3: 201-206.), 헴프씨드 내의 항산화 활성의 펩타이트(Lu RR, 등, 2010. Food Chem 123: 1210-1218), 항고혈압성 펩타이드(Girgih AT 등, 2014. J. Funct Foods 6: 384-394) 및 신경세포 항염증 및 신경세포 보호 활성(Zhou Y 등, 2018. Phytochem Lett 23: 57-61) 등의 활성이 알려져 있다. 또한, 헴프씨드의 섭취에 의한 인지기능의 개선(배길준 외, 2015, Journal of Korean Medicine Rehabilitation 25: 1-15) 및 아토피 피부염 완화(박신희, 2018, 조선대학교 박사논문)가 알려져 있다. 또한, 혈전증과 관련하여 헴프씨드를 식이로 공급한 경우의 렛트에서의 혈소판 응집저해 활성이 보고(Richard MN 등, 2007, Journal of thrombosis and haemostasis, 5: 424-425)된 바 있으나, 이는 헴프씨드의 리놀레산(linoleic acid, LA) 및 알파-리놀렌산(alpha-linolenic acid, ALA) 등의 다가불포화지방산에 의한 것으로 알려져 있다. Studies related to hemp seeds include fatty acid analysis (Koh DH, 1990, Korean J Food Nutr 3: 201-206.), peptides with antioxidant activity in hemp seeds (Lu RR, et al., 2010. Food Chem 123: 1210- 1218), antihypertensive peptide (Girgih AT et al., 2014. J. Funct Foods 6: 384-394) and neuronal anti-inflammatory and neuroprotective activity (Zhou Y et al., 2018. Phytochem Lett 23: 57-61), etc. The activity of is known. In addition, the ingestion of hemp seeds is known to improve cognitive function (Bae Gil-jun et al., 2015, Journal of Korean Medicine Rehabilitation 25: 1-15) and alleviate atopic dermatitis (Park Shin-hee, 2018, doctoral thesis at Chosun University). In addition, in relation to thrombosis, platelet aggregation inhibitory activity in rats when hemp seeds were fed as a diet has been reported (Richard MN et al., 2007, Journal of thrombosis and haemostasis, 5: 424-425), but this It is known to be caused by polyunsaturated fatty acids such as linoleic acid (LA) and alpha-linolenic acid (ALA).
또한, 헴프씨드와 관련된 특허로는 대한민국 등록특허 제10-1844849호 [헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그 제조 방법], 제10-1828217호 [대마씨 및 광천수를 배지로 한 동충하초 배양 및 생육방법], 제10-1492976호 [대마씨 성분이 함유된 면 및 그 제조방법], 제10-1886421호 [대마씨를 이용한 두부제조방법], 제10-2030923호 [햄프씨드를 이용한 두부형태의 가공식품 및 그 제조방법], 제10-1921331호 [대마씨를 함유한 육개장 칼국수와 그 제조방법], 제10-1820836호 [대마씨앗을 이용한 과립의 제조방법], 제10-1811000호 [청삼 종실유 및 그의 제조방법], 제10-0829997호 [청삼 종실유의 제조방법 및 그에 의해 제조된 청삼 종실유], 제10-0829999호 [청삼 종실유의 4급 아민염 제조방법 및 그에 의해 제조된 청삼 종실유의 4급 아민염], 제10-1871343호 [탈모 방지 비누의 제조방법], 제10-2011349호 [항고혈압 활성이 개선된 혼합 씨앗즙] 및 일본특허 JP-0044143호 [PRODUCTION OF MISO CONTAINING THRESHED HEMPSEED]가 개시되어 있다. In addition, patents related to hemp seeds include Republic of Korea Patent No. 10-1844849 [Complex composition containing hemp seed oil and kenaf seed oil and method for manufacturing the same], No. 10-1828217 [Hemp seeds and mineral water as medium] Cordyceps sinensis culture and growth method], No. 10-1492976 [Noodles containing hemp seed ingredients and its manufacturing method], No. 10-1886421 [Tofu manufacturing method using hemp seeds], No. 10-2030923 [Hemp seeds Processed food in the form of tofu and its manufacturing method], No. 10-1921331 [Yukgaejang kalguksu containing hemp seeds and its manufacturing method], No. 10-1820836 [Method for manufacturing granules using hemp seeds], No. 10-1811000 No. [Cheongsam seed oil and its manufacturing method], No. 10-0829997 [Cheongsam seed oil and its manufacturing method], No. 10-0829999 [Cheongsam seed oil's quaternary amine salt manufacturing method and the same. Quaternary amine salt of manufactured Cheongsam seed oil], No. 10-1871343 [Manufacturing method of anti-hair loss soap], No. 10-2011349 [Mixed seed juice with improved antihypertensive activity], and Japanese Patent JP-0044143 [PRODUCTION] OF MISO CONTAINING THRESHED HEMPSEED] is disclosed.
또한, 대한민국 공개특허 제10-2012-0111125호 [마자인 추출물을 포함하는 신장암 치료용 조성물 및 건강 기능성 식품], 제10-2012-0111126호 [마자인 추출물을 포함하는 췌장암 치료용 조성물 및 건강 기능성 식품], 제10-2010-0008541호 [괄루인 또는 마자인 추출물을 함유하는 인간 중간엽 줄기세포의 지방세포로의 분화 촉진용 조성물]이 공개되어 있으며, 제10-2019-0066702호 [대마씨 음료 및 그 제조방법], 제10-2019-0068982호 [대마씨에서 단백질 및/또는 지방을 추출하는 방법], 제10-2019-0087701호 [시린이 방지용 대마씨유와 참마를 함유하는 치약조성물], 제10-2019-0066701호 [대마씨 탈각을 위한 전처리 방법], 제10-2017-0128028호 [대마씨를 함유하는 기능성 국수와 기능성 국수의 제조방법], 제10-2014-0081966호 [초임계유체를 이용한 청삼 종실유의 추출방법 및 그에 의해 제조된 청삼 종실유], 제10-2014-0081967호 [청삼 종실유를 함유한 아토피 피부 개선 기능성 화장품 조성물], 제10-2016-0014963호 [헴프팩 및 이의 제조방법], 제10-2013-0076658호 [한약밥 처방명과 당뇨밥]이 공개되어 있으며, 국제특허 WO-9531176호 [COSMETIC PRODUCT CONTAINING HEMPSEED OIL AND METHOD FOR MANUFACTURING THE SAME], WO-0180358호 [AGENT FOR PROMOTING HAIR GROWTH AND METHOD FOR PREPARING SAME]이 공개되어 있다. In addition, Republic of Korea Patent Publication Nos. 10-2012-0111125 [Composition for treating kidney cancer and health functional food containing majaine extract], No. 10-2012-0111126 [Composition for treating pancreatic cancer and health containing majaine extract] Functional food], No. 10-2010-0008541 [Composition for promoting differentiation of human mesenchymal stem cells into adipocytes containing guaruin or majain extract] are disclosed, and No. 10-2019-0066702 [Hemp seed] Beverage and its manufacturing method], No. 10-2019-0068982 [Method for extracting protein and/or fat from hemp seeds], No. 10-2019-0087701 [Toothpaste composition containing hemp seed oil and yam for preventing cold teeth ], No. 10-2019-0066701 [Pretreatment method for shelling hemp seeds], No. 10-2017-0128028 [Functional noodles containing hemp seeds and manufacturing method of functional noodles], No. 10-2014-0081966 [Sec. Extraction method of Cheongsam seed oil using critical fluid and Cheongsam seed oil produced thereby], No. 10-2014-0081967 [Atopic skin improvement functional cosmetic composition containing Cheongsam seed oil], No. 10-2016-0014963 [Hemp Pack and its manufacturing method], No. 10-2013-0076658 [Herbal medicine rice prescription name and diabetic rice] are published, and International Patent No. WO-9531176 [COSMETIC PRODUCT CONTAINING HEMPSEED OIL AND METHOD FOR MANUFACTURING THE SAME], WO-0180358 The issue [AGENT FOR PROMOTING HAIR GROWTH AND METHOD FOR PREPARING SAME] is open.
한편, 해방풍(Glehnia littoralis)은 산형과(Umbelliferae)의 여러해살이 풀로 우리나라 해안가 모래땅에 염생식물로 자생하며, 그 뿌리를 약용으로, 지상부 잎은 특유의 향이 있는 허브로 식용하고 있다. 특히, 뿌리는 방풍의 대용으로 사용하여, 갯방풍, 빈방풍(濱防風), 해사삼이라고도 불리며, 한방에서는 발한, 해열, 진통약으로 사용하고 있다. Meanwhile, Glehnia littoralis is a perennial herb of the Umbelliferae family that grows naturally as a halophyte in the sandy soil along the coast of Korea. Its roots are used for medicinal purposes, and the above-ground leaves are eaten as an herb with a unique aroma. In particular, the root is used as a substitute for windbreak, and is also called Gaetbangpung, Binbangpung (濱防風), and sea sand ginseng. In Oriental medicine, it is used as a sweating, antipyretic, and painkiller.
흔히 알려진 풍을 방지한다는 방풍은 Ledebouriella seseloides 또는 Saposhikovia divaricata의 뿌리를 말하며, 식용으로 사용하는 식방풍(갯기름나물의 뿌리, 미역방풍, 목단방풍, 산방풍, 목방풍으로도 불린다.)은 Peucedanum japonicum Thunberg의 뿌리를 말하는 것으로, 본 발명의 해방풍과는 식물 분류학상, 용도 및 효능상으로도 차이가 있다. The commonly known wind-prevention plant refers to the roots of Ledebouriella seseloides or Saposhikovia divaricata , and the edible plant-based plant (also called seaweed plant root, seaweed plant, mokdanfang, sanbangpung, and mokbangpung) is Peucedanum japonicum . It refers to the root of Thunberg, and is different from the liberation of the present invention in terms of plant taxonomy, use, and efficacy.
국내의 경우, 해방풍은 해안선을 따라 일부 자생지가 형성되어 있으나, 최근에는 재배기술의 발달로 해안가에서 노지 재배 또는 하우스 재배를 통해 대량 생산되고 있으며, 노지 재배시와 하우스 재배시 성분 및 효능의 차이가 있음이 알려져 있다(Woo et. al., 45th Annual Meeting & International Symposium, KMB 2018; Woo et. al., The 59th Annual Meeting and International Symposium of Korean Society of Life Science; Woo et. al., The 59th Annual Meeting and International Symposium of Korean Society of Life Science). In the case of Korea, Liberation Pung has some natural habitats along the coastline, but recently, with the development of cultivation technology, it is mass-produced along the coast through open field or house cultivation. There is a difference in ingredients and efficacy when cultivated in the open field and in the house. It is known that there is (Woo et. al., 45th Annual Meeting & International Symposium, KMB 2018; Woo et. al., The 59th Annual Meeting and International Symposium of Korean Society of Life Science; Woo et. al., The 59th Annual Meeting and International Symposium of Korean Society of Life Science).
해방풍에 대한 연구는 뿌리에 대한 성분 및 효능 연구가 대부분이며, 식용으로 이용되고 있는 지상부에 대한 연구는 매우 미미한 상태이다. 먼저, 뿌리의 경우, coumarin, polyacetylene, lignan, monoterpenoid 류에 속하는 성분들이 보고되었으며(Zhao Y 등, 2007, Yao Xue Xue Bao. 42: 1070-1073; 엄영란 외, 2010, J. Korean Chemical Soc 54: 701-706), 최근에는 해방풍 열매와 전초에서 monoterpenoid, alkyl glycoside, aromatic glycoside, phenolic acids(Chlorogenic acid, quercetin-3-glucoside) 및 pyranocoumarin 류가 확인된 바 있다(김현정, 2015. 목포대학교 석사논문). Most research on Haebangpung focuses on the ingredients and efficacy of the root, and very little research is done on the above-ground part, which is used for food. First, in the case of roots, components belonging to the coumarin, polyacetylene, lignan, and monoterpenoid classes were reported (Zhao Y et al., 2007, Yao Xue 701-706), and recently, monoterpenoids, alkyl glycosides, aromatic glycosides, phenolic acids (Chlorogenic acid, quercetin-3-glucoside), and pyranocoumarins have been identified in the fruits and whole plants of Haebangpung (Hyeonjeong Kim, 2015. Master's thesis, Mokpo National University) .
해방풍 뿌리의 주요 약리활성으로 항산화, 항염증, 항세균(Matsuura H 등, 1996, Planta Med. 62: 256-259), 항곰팡이 활성(McCutcheon AR 등, 1994. J Ethnopharmacol. 44: 157-169), 암세포 생육 억제 활성(김지훈 외, 2008. Korean J. Medicinal Crop Science 16: 44-50) 및 thromboxane 합성 저해에 따른 혈소판 응집 저해활성(Wang SR, 1993, Zhongguo Zhong Xi Yi Jie He Za Zhi, 13: 167-170)이 알려져 있다. 또한, 해방풍 메탄올 추출물의 peroxynitrite 소거 활성(이희정,외, 2004. Korean J. Biotechnol Bioeng. 19: 57-61), 알파 아마니틴에 의한 간독성에 대한 해방풍의 보호 효과(김보현 외, 2017, 대한임상독성학회지, 15: 107-115) 및 해방풍의 캘러스 유도 및 식물체 재분화 연구(이병국 외, 2004. Korean J Plant Res 17: 153-160) 등이 알려져 있다. The main pharmacological activities of Haebangpung root are antioxidant, anti-inflammatory, antibacterial (Matsuura H et al., 1996, Planta Med. 62: 256-259), and antifungal activity (McCutcheon AR et al., 1994. J Ethnopharmacol. 44: 157-169). , cancer cell growth inhibitory activity (Kim Ji-hoon et al., 2008. Korean J. Medicinal Crop Science 16: 44-50) and platelet aggregation inhibitory activity due to inhibition of thromboxane synthesis (Wang SR, 1993, Zhongguo Zhong Xi Yi Jie He Za Zhi, 13: 167-170) is known. In addition, the peroxynitrite scavenging activity of the methanol extract of Haebangpung (Heejeong Lee, et al., 2004. Korean J. Biotechnol Bioeng. 19: 57-61), and the protective effect of Haebangpung against hepatotoxicity caused by alpha-amanitin (Bohyun Kim et al., 2017, Korean Clinical Toxicology Journal of the Society, 15: 107-115) and research on callus induction and plant redifferentiation in Haebangpung (Byung-Guk Lee et al., 2004. Korean J Plant Res 17: 153-160) are known.
해방풍의 지상부와 관련한 연구로는, 해방풍 어린 잎 정유 및 그 주성분의 항생제 감수성 및 내성 Streptococcus pneumoniae 균주에 대한 억제 효과가 보고되어 있으며(신승원, 2005. 약학회지 49: 312-316), 해방풍 뿌리를 포함하는 전초로부터 6-carboxyethyl-4,7-dimethoxy-5-hydroxybenzofuran, 5-O-β-D-glucopyranoside, chlorogenic acid, 3'-O-methylchlorogenic acid, quercetin 3-O-β-D-glucoside, quercetin 3-O-rutinoside, kaempferol 3-O-rutinoside 등을 확인하여 이들의 항응고 활성을 보고한 바 있다(임현진, 김현정 외, 2016. 생약학회지 47: 49-54; 김현정, 2015. 목포대학교 석사논문). In studies related to the aerial parts of Haebangpung, the inhibitory effect of Haebangpung young leaf essential oil and its main components on antibiotic-susceptible and resistant Streptococcus pneumoniae strains was reported (Seung-won Shin, 2005. Journal of Pharmacy 49: 312-316), including the roots of Haebangpung. From the outpost, 6-carboxyethyl-4,7-dimethoxy-5-hydroxybenzofuran, 5-O-β-D-glucopyranoside, chlorogenic acid, 3'-O-methylchlorogenic acid, quercetin 3-O-β-D-glucoside, quercetin 3-O-rutinoside, kaempferol 3-O-rutinoside, etc. have been identified and their anticoagulant activity has been reported (Hyunjin Lim, Hyunjeong Kim et al., 2016. Journal of Herbal Medicine 47: 49-54; Hyunjeong Kim, 2015. Master's thesis, Mokpo National University) ).
또한, 해방풍과 관련된 특허로는 대한민국 등록특허 제10-1787566호에 해방풍 전초 추출물의 부탄올 분획물을 유효성분으로 하는 [갯방풍 추출물을 포함하는 심혈관계 질환의 예방 또는 치료용 약학 조성물]이 알려져 있으며, 등록특허 제10-1620153호에는 [갯방풍 추출물을 유효성분으로 포함하는 관절염 예방 또는 치료용 조성물]이, 등록특허 제10-1817242호에는 [갯방풍 추출물을 함유하는 피부 외용제 조성물]이 알려져 있다. 또한, 등록특허 제10-1164083호에는 [해방풍 추출물을 유효성분으로 함유하는 숙취해소용 조성물]이, 제10-1207214호에는 [해방풍 추출물로부터 제조한 분획물을 유효성분으로 함유하는 염증성 질환의 예방 및 치료용 조성물]이, 제10-0919852호에는 [해방풍 추출물을 유효성분으로 함유하는 부종 또는 피부염예방 및 치료용 조성물]이, 제10-1413363호에는 [PGE2 활성을 조절하는 해방풍 추출물의 용도]기 알려져 있다. 또한, 최근 식품용 해방풍 특허로는 등록특허 제10-1867480호에 [식품첨가용 갯방풍 추출물의 제조방법]이, 제10-1812258호에는 [해방풍을 이용한 약주 및 탁주 제조 방법]이, 제10-1789183호에는 [갯방풍이 첨가된 국수의 제조방법], 제10-1610267호에는 [갯방풍이 첨가된 더치커피의 제조방법]이 알려져 있다. 또한, 공개특허 제10-2014-0077483호에는 뇌신경세포 사멸을 억제하는 효능을 가진 [갯방풍 추출물을 포함하는 허혈성 뇌혈관 질환 예방 또는 개선용 조성물]이, 제10-2010-0037781호에는 [갯방풍 추출물을 함유하는 암예방 및 치료용 약학적 조성물]이, 제10-2018-0067861호에는 [갯방풍 장아찌의 제조방법] 및 제10-2015-0064864호에는 [갯방풍 잎차 및 이의 제조방법]이 공개되어 있다. In addition, as a patent related to Haebangpung, Republic of Korea Patent No. 10-1787566 discloses [Pharmaceutical composition for the prevention or treatment of cardiovascular diseases containing Haebangpung extract], which contains the butanol fraction of Haebangpung whole plant extract as an active ingredient. Registered Patent No. 10-1620153 discloses [Composition for preventing or treating arthritis containing extract of Gaetbang as an active ingredient], and [Composition for topical skin application containing extract of Gaetbang] is known in Patent No. 10-1817242. In addition, Registration Patent No. 10-1164083 discloses [A composition for relieving hangovers containing Haebangpung extract as an active ingredient], and No. 10-1207214 discloses [A composition for the prevention of inflammatory diseases containing a fraction prepared from Haebangpung extract as an active ingredient]. Therapeutic Composition], No. 10-0919852, [Composition for preventing and treating edema or dermatitis containing Haebangpung extract as an active ingredient], and No. 10-1413363, [Use of Haebangpung extract to regulate PGE2 activity]. It is known. In addition, recent patents for Haebangpung for food include [Method for manufacturing Gaetbangpung extract for food additives] in Registration Patent No. 10-1867480, [Method for manufacturing Yakju and Takju using Haebangpung] in No. 10-1812258, and No. 10. In No. -1789183, [Method for manufacturing noodles with Gaetbangpung added], and in No. 10-1610267, [Method for producing Dutch coffee with Gaetbangpung added] is known. In addition, Publication Patent Publication No. 10-2014-0077483 discloses [Composition for preventing or improving ischemic cerebrovascular disease containing extract of Gaetbang fir], which has the effect of inhibiting brain nerve cell death, and No. 10-2010-0037781 discloses [Composition for preventing or improving ischemic cerebrovascular disease], which has the effect of inhibiting brain nerve cell death. Pharmaceutical composition for cancer prevention and treatment containing extract of Bangpung], No. 10-2018-0067861 [Method for manufacturing Gaetbangpung pickled vegetables], and No. 10-2015-0064864 [Gaetbangpung leaf tea and manufacturing method thereof]. This is public.
한편, 마(yam)는 백합목 마과의 덩굴성 여러해살이풀로 높이는 1m 정도이며, 그 지상부는 덩굴이며, 지하부 뿌리는 약용 및 식용으로 사용된다. 전 세계적으로 마는 장마(Dioscorea batatas), 단마(Dioscorea opposita), 환마, 둥근마, 산마, 부채마, 단풍마 등 600 여종이 알려져 있으며, 그 중 10 여종이 식용 및 약용으로 사용되어 왔다. 마의 원산지는 중국이며, 한국, 중국, 타이완, 일본 등지의 산지에서 자생하기도 하며, 국내에서는 식약청이 식품원료로 지정한 한약재로, 마의 뿌리를 건조시켜 말린 것을 한방에서는 '산약' 또는 '서예'라고 부르며, 당뇨, 설사, 대하증 등에 이용된다. 마의 성분으로는 수분함량 74~76%, 전분 15~20%, 단백질 1~1.5%, 총지질 ~1%, 회분 ~1.25%, 총질소함량 ~0.4%, 수분함량 ~74%이며, 점질다당류(acetylated glucomannan), 비타민, 미네랄, 기타 다양한 생리활성물질 등을 포함하고 있으며, 보고된 약용성분으로는 Amylose, Choline, Saponin, Mucin, Araginine, Yonogenin, Kryptogenin, Diosgenin 등이 있다. On the other hand, yam is a climbing perennial plant of the Liliaceae Yam family, with a height of about 1 m, its above-ground part is a vine, and its underground roots are used for medicinal and edible purposes. There are about 600 species of yam known around the world, including long yam ( Dioscorea batatas ), short yam ( Dioscorea opposita ), hwan yam, round yam, mountain yam, fan yam, and maple yam, and about ten of them have been used for food and medicinal purposes. The origin of yam is China, and it grows wild in producing areas in Korea, China, Taiwan, and Japan. In Korea, it is an herbal medicine designated by the Food and Drug Administration as a food ingredient. In oriental medicine, the dried yam root is called 'sanyak' or 'seoye'. It is used for diabetes, diarrhea, diarrhea, etc. The ingredients of yam include moisture content of 74-76%, starch 15-20%, protein 1-1.5%, total lipid ~1%, ash ~1.25%, total nitrogen content ~0.4%, moisture content ~74%, and viscous polysaccharide. It contains (acetylated glucomannan), vitamins, minerals, and various other biologically active substances, and reported medicinal ingredients include Amylose, Choline, Saponin, Mucin, Araginine, Yonogenin, Kryptogenin, and Diosgenin.
현재까지 마를 이용한 가공식품 개발 연구의 경우, 마를 유산균에 접종시켜 만든 발효액(고록, 2014. 서울대학교 석사논문; 송봉준, 2011. 원광대학교 박사논문; 임성원 외, 2011. 약학회지 55: 404-410; 현미선 외 2011, J. Appl. Biol. Chem. 54: 51-55)이 가장 일반적이며, 최근에는 Monascus sp. 또는 Aspergillus sp.의 곰팡이를 마에 접종하여 제조하는 고체 발효마가 보고되어 있다(전춘표 외, 2012, Korean Journal of Microbiology. 48: 29-36; 전춘표, 2014. Korean Journal of Microbiology 50: 46-52; 이준걸 2014. Korean Journal of Microbiology 50: 53-59). 또한, 마를 장수상황버섯으로 고체 발효시켜 기능성과 관능성을 강화하려는 연구도 보고(손호용 외, 2010, Journal of Life Science 20: 1268~1275)되어 있으며, 마 분말을 첨가하여 제조한 두부(김정선 2010, 영남대학교 박사논문: 마 가공식품의 인식 및 기호도 실태조사와 가공제품 개발에 관한 연구)가 알려져 있다. 이러한 마 가공식품은 대식세포 활성화 효능, 항비만 효능, GABA 생성 증대, 항산화 활성 증대 효과 및 배변 촉진활성이 있음이 확인되어 있다.In the case of research on the development of processed foods using yam to date, fermentation broth made by inoculating yam with lactic acid bacteria (Gorok, 2014. Master's thesis, Seoul National University; Bongjun Song, 2011. Doctoral thesis, Wonkwang University; Seongwon Lim et al., 2011. Journal of Pharmaceutical Sciences 55: 404-410; Hyeon Mi-seon et al. 2011, J. Biol 54: 51-55) is the most common, and recently, Monascus sp. Alternatively, solid fermented yam manufactured by inoculating yam with the mold of Aspergillus sp. has been reported (Jeon Chun-pyo et al., 2012, Korean Journal of Microbiology. 48: 29-36; Jeon Chun-pyo, 2014. Korean Journal of Microbiology 50: 46-52 ; Lee Jun-geol 2014. Korean Journal of Microbiology 50: 53-59). In addition, research has been reported to enhance functionality and sensuality by solid-fermenting yam with longevity shanghai mushrooms (Son Ho-yong et al., 2010, Journal of Life Science 20: 1268-1275), and tofu manufactured by adding yam powder (Kim Jeong-seon 2010) , Yeungnam University doctoral thesis: A survey on the perception and preference of hemp processed foods and a study on the development of processed products) is known. These yam processed foods have been confirmed to have a macrophage activation effect, anti-obesity effect, increased GABA production, increased antioxidant activity, and defecation promoting activity.
마와 관련된 식품 제조 특허로는, 대한민국 등록특허 제10-1790334호에 "참마를 이용한 기능성 순대 제조방법", 제10-1139767호에 "참마튀김 제조방법", 제10-1414445호에 "참마 찰순대의 제조방법", 제10-1862817호에 "안동참마를 포함하는 안동참마 고기볶음장 및 그 제조방법"이 개시되어 있으며, 제10-1534387호에 "발효 산약 분말을 첨가한 항산화, 항고혈압 활성을 나타내는 GABA 고함유 기능성 요구르트 및 이의 제조방법", 제10-1405827호에 "아토피 예방을 위한 발효추출물 및 이를 이용한 화장료 조성물", 제10-1377405호에 "장 기능 및 변비 개선 효과를 나타내는 유산균을 이용한 산약 발효물의 제조방법", 제10-1284187호에 "유산균 발효를 이용한 항염 효과가 증대된 산약 발효물의 제조방법", 제10-1280852호에 "마(산약) 발효물 및 이의 제조 방법", 제10-1234855호에 "산약을 이용한 식품 조성물 및 이의 제조 방법", 제10-0716123호에 "마 또는 산약의 유산 발효액을 함유하는 변비 및 비만의 예방 및 개선용 식품 조성물", 제10-1145426호에 "혈류 개선용 조성물, 이의 제조 방법 및 이를 포함하는 건강기능식품"이 개시되어 있다. Food manufacturing patents related to yams include Korean Patent No. 10-1790334 titled “Functional sundae manufacturing method using yam,” No. 10-1139767 titled “Yam frying method manufacturing method,” and No. 10-1414445 titled “Yam Chal.” In No. 10-1862817, “Method for manufacturing sundae,” “Andong yam stir-fried meat containing Andong yam and its manufacturing method,” are disclosed, and in No. 10-1534387, “Antioxidant and antihypertensive with fermented acid powder added. “Active GABA-high content functional yogurt and its manufacturing method”, No. 10-1405827, “Fermented extract for preventing atopy and cosmetic composition using the same”, No. 10-1377405, “Lactobacillus showing effects of improving intestinal function and constipation “Manufacturing method of fermented acidic medicinal products using”, No. 10-1284187, “Method of producing fermented acidic medicinal products with increased anti-inflammatory effect using lactic acid bacteria fermentation”, No. 10-1280852, “Yam (acidic acid) fermented product and method for manufacturing thereof” , No. 10-1234855, “Food composition using acid herb and manufacturing method thereof,” No. 10-0716123, “Food composition for preventing and improving constipation and obesity containing lactic acid fermentation broth of hemp or acid herb,” No. 10- No. 1145426 discloses “a composition for improving blood flow, a method for producing the same, and a health functional food containing the same.”
또한, 공개특허 제10-2017-0017954호에 "냉동 유통 참마 보리빵 및 이의 제조 방법", 제10-2019-0090097호에 "안동참마식혜 및 이의 제조방법" 및 제10-2006-0007426호에 "대두 성분 함유 식품의 원료, 그 원료를 사용한 대두 성분함유 식품, 및 상기 대두 성분 함유 식품의 제조 방법"이 공개되어 있는 등 참마의 유용생리활성과 뮤신성분은 위벽보호 및 혈당저하, 발암억제 등의 다양한 효능이 있어, 참마 가공식품은 소화기계 부담없이 즐길 수 있는 장점이 있다.In addition, in Publication Patent Nos. 10-2017-0017954, “Frozen yam barley bread and manufacturing method thereof,” in No. 10-2019-0090097, “Andong yam sikhye and manufacturing method thereof,” and in No. 10-2006-0007426. "The raw materials for foods containing soy ingredients, the foods containing soy ingredients using the raw materials, and the manufacturing method of the foods containing soy ingredients," are disclosed, and the useful physiological activities and mucin components of yam are used to protect the stomach lining, lower blood sugar, and inhibit carcinogenesis. Due to its various health benefits, processed yam foods have the advantage of being able to be enjoyed without burdening the digestive system.
한편, 죽과 관련된 연구로는 뽕잎분말과 오디분말의 최적 혼합비율을 이용한 기능성 죽 제조(김유진 외, 2017. 한국식품영양과학회지, 46: 1081-1090), 자색당근을 첨가한 기능성 죽의 품질 특성 및 항산화 활성(이수용 외, 2020. 한국조리학회, 26: 85-93), 다시마를 첨가한 건강기능성 죽의 품질특성 및 항산화 효과(이용수 외, 2017. 한국수산과학회 양식분과 학술대회 p 178), 더덕FD분말과 헛개추출분말 첨가량을 달리하여 제조한 기능성 분말죽의 이화학적 관능적 품질 특성 모니터링(이용수 외, 2011. 동아시아식생활학회 학술발표대회논문집 p 140) 등이 있으며, 마 가공처리를 달리한 마죽의 품질특성(이용수 외, 2017. 13: 49-60)이 보고되어 있다. Meanwhile, research related to porridge includes manufacturing functional porridge using the optimal mixing ratio of mulberry leaf powder and mulberry powder (Kim Yu-jin et al., 2017. Journal of the Korean Society of Food and Nutrition Science, 46: 1081-1090), and the quality of functional porridge with purple carrots. Characteristics and antioxidant activity (Lee Soo-yong et al., 2020. Korean Institute of Culinary Arts, 26: 85-93), quality characteristics and antioxidant effect of health functional porridge with kelp (Lee Yong-su et al., 2017. Korean Society of Fisheries Science and Aquaculture Division Conference p. 178) , monitoring of physicochemical and sensory quality characteristics of functional powdered porridge manufactured by adding different amounts of Deodeok FD powder and Hovenia extract powder (Yongsu Lee et al., 2011. East Asian Society of Dietetics Conference Paper p. 140), etc. The quality characteristics of hemp bamboo (Lee Yong-soo et al., 2017. 13: 49-60) have been reported.
또한, 죽과 관련된 특허로는, 대한민국 등록특허 제10-2223506호에 [한방 재료를 이용한 기능성 죽 조성물 및 이의 제조방법], 제10-1441565호에 [쌀 혼합물 및 안정화된 미강을 함유하는 기능성 죽 프리믹스 및 이의 제조방법], 제10-1853654호에 [배아미와 이슬송이버섯 및 아이스플랜트를 이용한 쌀눈 죽 제조방법], 제10-1959191호에 [유황현미쌀과 고소애를 유효성분으로 함유하는 면역기능성 죽 제조방법], 제10-1301926호에 [당뇨환자용 즉석죽 및 그 제조 방법, 즉석죽용 프리믹스] 등이 개시되어 있으며, 대마 종실 및 헴프씨드와 관련된 죽으로는 대한민국 등록특허 제10-0812759호에 [청삼종실죽의 제조방법 및 그에 의해 제조된 청삼종실죽]이 알려져 있으며, 방풍과 관련된 죽으로는 제10-1886851호에 [방풍 피고막 죽의 제조방법 및 이에 따라 제조된 방풍 피고막 죽]이 알려져 있다. 또한, 공개특허 제10-2020-0116381호에 [고영양 고기능성 환자식 케어푸드 쌀눈죽], 제10-2020-0116376호에 [고영양 고기능성 임산부용 수유와 붓기감소,독소배출에 효과적인 간편식 전복쌀눈죽], 제10-2013-0133310호에 [서동마를 이용한 마죽 제조방법], 제10-2019-0001719호에 [뽕잎분말과 오디분말의 첨가 혼합율을 최적화한 기능성죽 제법] 등이 공개되어 있으나, 현재까지 헴프씨드, 해방풍, 마를 이용한 항산화, 항당뇨, 항혈전 활성이 우수하면서 동결건조되어 저장성, 휴대성이 우수하면서, 물만 부어 먹을수 있는 간편 기능성 죽에 대한 보고는 알려진 바 없다. In addition, patents related to porridge include Republic of Korea Patent No. 10-2223506 [Functional porridge composition using oriental medicine ingredients and manufacturing method thereof], and No. 10-1441565 [Functional porridge containing rice mixture and stabilized rice bran] Premix and its manufacturing method], No. 10-1853654 [Rice germ porridge manufacturing method using embryonic rice, dewdrop mushroom, and ice plant], No. 10-1959191 [Immune product containing sulfur brown rice and high-alcohol as active ingredients [Functional porridge manufacturing method], [Instant porridge for diabetic patients and its manufacturing method, premix for instant porridge], etc. are disclosed in No. 10-1301926, and porridge related to hemp seeds and hemp seeds is disclosed in Republic of Korea Patent No. 10-0812759. [Manufacturing method of Cheongsam species porridge and Cheongsam species porridge manufactured thereby] are known, and as porridge related to windbreak, No. 10-1886851 [Method of manufacturing windproof porridge and windproof porridge manufactured accordingly] are known. ] is known. In addition, Publication Patent No. 10-2020-0116381 [Highly nutritious and highly functional patient care food rice germ] and No. 10-2020-0116376 [Highly nutritious and highly functional convenient food for pregnant women that is effective in breastfeeding, reducing swelling and eliminating toxins] Abalone rice bran porridge], [Method of manufacturing yam porridge using Seodong yam] in No. 10-2013-0133310, and [Functional porridge manufacturing method optimizing the addition mixing ratio of mulberry leaf powder and mulberry powder] in No. 10-2019-0001719 were published. However, to date, there has been no known report on a simple functional porridge using hemp seeds, Haebangpung, and hemp that has excellent antioxidant, anti-diabetic, and anti-thrombotic activities, is freeze-dried, has excellent storage and portability, and can be consumed by just pouring water.
본 발명은 상기와 같은 종래 기술의 문제점을 해결하기 위하여 안출된 것으로서, 본 발명에서 해결하고자 하는 과제는 헴프씨드(Hempseed), 해방풍(Glehnia littoralis) 및 마(yam)를 포함하는 항산화, 항당뇨 및 항혈전의 생리 활성이 우수한 기능성 죽을 제공하고자 하는 것이다. 상기 헴프씨드, 해방풍 및 마를 포함하는 기능성 죽은 동결건조 분말로 조제되어 저장성과 휴대성이 우수하며, 가수, 가열의 간단한 처리로 남녀노소 누구나 간편하게 먹을 수 있는 장점을 가진다. The present invention was created to solve the problems of the prior art as described above, and the problem to be solved by the present invention is to provide anti-oxidant, anti-diabetic and anti-diabetic effects including hemp seed, Glehnia littoralis and yam. The goal is to provide functional porridge with excellent anti-thrombotic physiological activity. The functional porridge containing hemp seeds, haebangpung, and hemp is prepared as a freeze-dried powder and has excellent storage and portability, and has the advantage that anyone of any age can easily eat it by simple processing of water and heating.
상기와 같은 과제를 해결하기 위하여, 본 발명은 헴프씨드(Hempseed), 해방풍(Glehnia littoralis) 및 마(yam)를 포함하는 죽을 제공한다.In order to solve the above problems, the present invention provides porridge containing hempseed, Glehnia littoralis , and yam.
상기 죽은 멥쌀죽을 베이스로 헴프씨드 3~5중량%, 해방풍 1.5~2중량% 및 마 2~2.5중량%를 포함하는 것이 바람직하다.It is preferable that the non-glutinous rice porridge contains 3 to 5% by weight of hemp seed, 1.5 to 2% by weight of Haebangpung, and 2 to 2.5% by weight of hemp.
상기 죽은 항산화, 항당뇨 및 항혈전으로 이루어지는 군으로부터 선택되는 기능성을 갖는 것이 바람직하다.The porridge preferably has functionality selected from the group consisting of antioxidant, anti-diabetic, and anti-thrombotic.
상기 죽은 동결건조된 형태인 것이 바람직하다.The porridge is preferably in freeze-dried form.
본 발명의 헴프씨드, 해방풍 및 마를 포함하는 기능성 죽은 관능성, 영양성, 저작성이 우수하며, 통상의 쌀죽에 비해 우수한 항산화, 항당뇨 및 항혈전 활성을 나타낸다. 또한, 상기 기능성 죽은 동결건조되어 간편하게 물만 부어 죽으로 만들어 간편성과 저장성이 우수하며, 헴프씨드 특유의 고소함과 해방풍과 마의 관능성을 기대할 수 있다.The functional porridge containing hemp seeds, Haebangpung and yam of the present invention has excellent organoleptic properties, nutritional properties and chewing properties, and exhibits excellent antioxidant, anti-diabetic and anti-thrombotic activities compared to conventional rice porridge. In addition, the functional porridge is freeze-dried and can be easily made into porridge by simply pouring water, so it has excellent convenience and storage, and you can expect the unique nutty flavor and libation of hemp seeds and the sensuality of yam.
도 1은 실험에 사용된 (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽, (3) 일반죽에 해방풍, 마 및 헴프씨드를 첨가하여 조제된 죽의 동결건조물 사진도이다.
도 2는 실험에 사용된 (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽, (3) 일반죽에 해방풍, 마 및 헴프씨드를 첨가하여 조제된 죽의 동결건조물에 물을 각각 5배 가수하여 복원한 죽의 사진도이다. Figure 1 is a photograph of the freeze-dried product of (1) regular porridge used in the experiment, (2) porridge prepared by adding Haebangpung and yam to regular porridge, and (3) porridge prepared by adding Haebangpung, yam and hemp seeds to regular porridge. .
Figure 2 shows water in the freeze-dried product of (1) regular porridge, (2) porridge prepared by adding Haebangpung and yam to regular porridge, and (3) porridge prepared by adding Haebangpung, yam and hemp seeds to regular porridge. This is a photo of rice porridge that was restored by multiplying the weight 5 times.
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 발명자들은 우수한 영양성과 다양한 유용생리활성을 나타내는 헴프씨드, 해방풍 및 마를 이용하여 기능성 죽을 제조하고자 하였으며, 상기 기능성 죽은 소화흡수가 용이하며, 식감이 우수하며 맛과 향이 우수한 특징을 가지며, 관능성 증대는 물론, 항산화, 항당뇨, 항혈전 활성도 증대시키는 효과를 가짐을 확인하였다. The inventors of the present invention attempted to manufacture functional porridge using hemp seeds, haebangpung, and hemp, which exhibit excellent nutritional properties and various useful physiological activities. The functional porridge is easy to digest and absorb, has excellent texture, excellent taste and aroma, and has sensory properties. It was confirmed that it has the effect of increasing antioxidant, anti-diabetic, and anti-thrombotic activities as well as increasing antioxidant properties.
따라서, 본 발명은 헴프씨드(Hempseed), 해방풍(Glehnia littoralis) 및 마(yam)를 포함하는 죽을 제공한다.Accordingly, the present invention provides porridge containing hempseed, Glehnia littoralis and yam.
상기 해방풍은 해방풍의 지상부인 것이 바람직하다.It is preferable that the above-mentioned liberating wind is an above-ground part of the liberating wind.
상기 죽은 멥쌀죽을 베이스로 헴프씨드 3~5중량%, 해방풍 1.5~2중량% 및 마 2~2.5중량%를 포함하는 것이 바람직하다.It is preferable that the non-glutinous rice porridge contains 3 to 5% by weight of hemp seed, 1.5 to 2% by weight of Haebangpung, and 2 to 2.5% by weight of hemp.
상기 멥쌀죽 베이스는 멥쌀, 양파, 당근, 호박, 표고버섯, 소고기, 쪽파 및 육수로 이루어지는 군으로부터 선택될 수 있으며, 예를 들어, 상기 멥쌀죽 베이스는 멥쌀 15중량%, 양파 2.3중량%, 당근 1.6중량%, 호박 1.6중량%, 표고버섯 1.6중량%, 소고기 3.0중량%, 쪽파 0.3중량% 및 육수 66.6중량%일 수 있다. The non-glutinous rice porridge base may be selected from the group consisting of non-glutinous rice, onions, carrots, pumpkin, shiitake mushrooms, beef, chives, and broth. For example, the non-glutinous rice porridge base includes 15% by weight of non-glutinous rice, 2.3% by weight of onions, and carrots. It may be 1.6% by weight, pumpkin 1.6% by weight, shiitake mushrooms 1.6% by weight, beef 3.0% by weight, chives 0.3% by weight, and broth 66.6% by weight.
상기 죽은 항산화, 항당뇨 및 항혈전으로 이루어지는 군으로부터 선택되는 기능성을 갖는 것이 바람직하다.The porridge preferably has functionality selected from the group consisting of antioxidant, anti-diabetic, and anti-thrombotic.
상기 죽은 동결건조된 형태인 것이 바람직하다.The porridge is preferably in freeze-dried form.
이하에서는 실시예를 통하여 본 발명을 더욱 상세하게 설명한다. 하기 실시예는 본 발명의 바람직한 일 구체예일 뿐이며, 본 발명의 권리범위가 하기 실시예의 범위로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. The following example is only a preferred embodiment of the present invention, and the scope of the present invention is not limited to the scope of the following example.
[실시예][Example]
실시예 1: 헴프씨드, 해방풍, 마를 포함하는 죽 제조 Example 1: Preparation of porridge containing hemp seeds, liberation wind, and hemp
시판 헴프씨드(캐나다산), 해방풍(식용 잎), 마를 구입하여 통상의 멥쌀죽 베이스에 각각 첨가하여 죽을 제조하고, 제조된 죽을 동결건조하였다. 각각의 죽 제조 레시피는 표 1 과 같다.Commercially available hemp seeds (from Canada), Haebangpung (edible leaves), and yam were purchased and added to a regular non-glutinous rice porridge base to prepare porridge, and the prepared porridge was freeze-dried. Each porridge manufacturing recipe is shown in Table 1.
[표 1] (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽 및 (3) 일반죽에 해방풍, 마 및 헴프씨드를 첨가하여 조제된 죽의 레시피 (단위 : g)[Table 1] Recipe for (1) regular porridge, (2) porridge made by adding Haebangpung and yam to regular porridge, and (3) porridge prepared by adding Haebangpung, yam, and hemp seeds to regular porridge (unit: g)
상기의 구성성분을 혼합하여 약불에서 저으면서 죽을 각각 제조하였으며, 제조된 죽은 동결건조기(일산베이스, 한국)를 이용하여 건조물을 조제하였다. 조제된 동결건조물의 사진도와 색차분석은 도 1 및 표 2에 나타내었다. Porridge was prepared by mixing the above components and stirring over low heat, and the dried product was prepared using a freeze dryer (Ilsan Base, Korea). Photographs and color difference analysis of the prepared freeze-dried product are shown in Figure 1 and Table 2.
[표 2] (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽 및 (3) 일반죽에 해방풍, 마, 헴프씨드를 첨가한 죽의 동결건조물의 색차[Table 2] Color difference of the freeze-dried product of (1) regular porridge, (2) porridge made by adding Haebangpung and yam to regular porridge, and (3) porridge added with Haebangpung, yam, and hemp seed to regular porridge.
도 1 및 표 2에 나타낸 바와 같이 일반죽 분말 (1)의 경우 일부 쌀의 형태가 유지되어 있으며, 53.85의 명도, 0.36의 적색도, 15.37의 황색도로 약간의 황색을 나타내었다. 일반죽에 해방풍 및 마를 첨가한 죽 분말 (2)의 경우 일반죽보다 높은 명도, 낮은 적색도, 높은 황색도를 나타내었으나, 전체적인 색차는 유사하였다. 반면, 일반죽에 해방풍, 마, 헴프씨드를 첨가하여 조제된 죽 분말 (3)의 경우 29.26의 낮은 명도, 4.5의 높은 적색도, 12.53의 낮은 적색도를 나타내어 기 제조한 죽분말보다 색차 차이가 컸다. 이는 헴프씨드가 첨가되어 죽으로 제조되는 가열처리 과정 중에 나타나는 특징적인 변화로 이해된다. As shown in Figure 1 and Table 2, in the case of general porridge powder (1), the shape of some rice was maintained, and it showed a slight yellow color with a brightness of 53.85, a redness of 0.36, and a yellowness of 15.37. Porridge powder (2), in which Haebangpung and hemp were added to regular porridge, showed higher brightness, lower redness, and higher yellowness than regular porridge, but the overall color difference was similar. On the other hand, the porridge powder (3) prepared by adding Haebangpung, hemp, and hemp seeds to regular porridge showed a low brightness of 29.26, a high redness of 4.5, and a low redness of 12.53, showing a larger color difference than the previously manufactured bamboo powder. . This is understood to be a characteristic change that occurs during the heat treatment process in which hemp seeds are added and made into porridge.
실시예 2: 제조된 동결건조죽의 수화 및 복원죽의 특성 평가 Example 2: Hydration of freeze-dried porridge and evaluation of properties of restored porridge
실시예 1에서 제조된 동결건조 죽 분말에 각각 5배의 물을 가하여 이화학적 특성 및 관능성을 평가하였다. 그 결과는, 도 2, 표 3 내지 표 5에 나타낸 바와 같이, 일반죽에 해방풍, 마, 헴프씨드를 첨가하여 조제된 죽 분말 (3)의 경우 38.07의 낮은 명도, 1.85의 높은 적색도를 나타내어 다소 어두운 붉은 색상을 나타내었다. 또한, 각각의 (1), (2), (3) 죽의 pH, brix, 산도를 측정한 결과, pH는 6.6으로 변화가 없었으나, brix와 산도는 (3)에서 유의적으로 높게 나타났다. 따라서, 헴프씨드, 해방풍, 마를 첨가하여 제조한 죽의 경우 통상의 쌀죽보다 관능성이 우수하였다.Five times the amount of water was added to the freeze-dried porridge powder prepared in Example 1, and the physicochemical properties and sensory properties were evaluated. As shown in Figure 2 and Tables 3 to 5, the porridge powder (3) prepared by adding Haebangpung, hemp, and hemp seeds to regular porridge showed a low brightness of 38.07 and a high redness of 1.85, which was somewhat It showed a dark red color. In addition, as a result of measuring the pH, brix, and acidity of each porridge (1), (2), and (3), the pH was unchanged at 6.6, but brix and acidity were significantly higher in (3). Therefore, porridge prepared by adding hemp seeds, Haebangpung, and hemp had superior sensory properties than ordinary rice porridge.
[표 3] (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽 및 (3) 일반죽에 해방풍, 마, 헴프씨드를 첨가한 죽의 동결건조물에 각각 5배의 물을 가하여 복원한 죽의 색차 [Table 3] Five times the amount of water was added to each of (1) regular porridge, (2) porridge with regular porridge added with Haebangpung and yam, and (3) porridge with regular porridge added with Haebangpung, hemp, and hemp seeds. Color difference of restored bamboo
[표 4] (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽 및 (3) 일반죽에 해방풍, 마, 헴프씨드를 첨가한 죽의 동결건조물에 각각 5배의 물을 가하여 복원한 죽의 pH, brix, 산도 [Table 4] Five times the amount of water was added to each of (1) regular porridge, (2) porridge with regular porridge added with Haebangpung and yam, and (3) porridge with regular porridge added with Haebangpung, hemp, and hemp seeds. pH, brix, and acidity of restored porridge
실제 식품영양학 전공 전문가 5인, 일반인 5명을 대상으로 5점 평가법으로 관능성을 평가한 결과, 헴프씨드, 해방풍, 마를 첨가하여 제조된 죽에서 가장 높은 맛과 향, 씹힙성, 목 넘김성, 전체적 선호도를 나타내었다(표 5).As a result of evaluating the sensory quality using a 5-point evaluation method for 5 food and nutrition experts and 5 ordinary people, the porridge made with hemp seeds, Haebangpung, and yam had the highest taste, aroma, chewiness, swallowing ability, and porridge. The overall preference was shown (Table 5).
[표 5] (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽 및 (3) 일반죽에 해방풍, 마, 헴프씨드를 첨가한 죽의 동결건조물에 각각 5배의 물을 가하여 복원한 죽의 관능성 평가[Table 5] Five times the amount of water was added to each of (1) regular porridge, (2) porridge with regular porridge added with Haebangpung and yam, and (3) porridge with regular porridge added with Haebangpung, hemp, and hemp seeds. Sensory evaluation of restored porridge
한편, 각각의 죽의 경도 평가결과 (3)의 헴프씨드를 첨가하여 제조한 죽이 죽 (1) 및 죽 (2)보다 월등히 낮은 경도를 나타내어 씹힙성과 목넘김 등의 관능성이 우수함을 확인하였다(표 6). 이때, 죽의 물성은 Texture analyzer FRTS-50N-1 (Imada Co. LTD., Japan)과 Force Recorder Professional Software(FRTS ver. 1.0)를 사용하여 측정하였으며, 3회 반복 측정후의 평균값을 나타내었다. 경도는 Disk probe를 사용하여 측정하였으며, compression speed는 2.0 mm/sec, compression displacement는 10 mm 조건을 설정하였다. Meanwhile, as a result of evaluating the hardness of each porridge, it was confirmed that the porridge prepared by adding hemp seeds in (3) showed much lower hardness than porridge (1) and porridge (2), showing excellent sensory properties such as chewability and swallowing ( Table 6). At this time, the physical properties of the bamboo were measured using Texture analyzer FRTS-50N-1 (Imada Co. LTD., Japan) and Force Recorder Professional Software (FRTS ver. 1.0), and the average value after three repeated measurements was shown. Hardness was measured using a disk probe, compression speed was set at 2.0 mm/sec, and compression displacement was set at 10 mm.
[표 6] (1) 일반죽, (2) 일반죽에 해방풍 및 마를 첨가한 죽 및 (3) 일반죽에 해방풍, 마, 헴프씨드를 첨가한 죽의 동결건조물에 각각 5배의 물을 가하여 복원한 죽의 경도 평가[Table 6] Five times the amount of water was added to each of (1) regular porridge, (2) porridge with regular porridge added with Haebangpung and yam, and (3) porridge with regular porridge added with Haebangpung, hemp, and hemp seeds. Hardness evaluation of restored bamboo
상기의 결과는 최근 식약처에서 인증한 고령친화식품의 1단계(치아섭취), 2단계(잇몸섭취), 3단계(혀로 섭취) 기준(표 7) 중에서 3단계(경도 20,000N/m2 이하, 점도 1500 mPa·s 이상에 해당하는 물성으로 고령친화식품의 최고단계인 3단계에도 적합한 무성을 나타냄을 확인하였다. The above results are based on level 3 (hardness 20,000 N/m 2 or less) among the 1st (teeth ingestion), 2nd (gum ingestion), and 3rd level (tongue ingestion) standards for senior-friendly foods recently certified by the Ministry of Food and Drug Safety (Table 7). , it was confirmed that it has a viscosity of over 1500 mPa·s and is suitable for level 3, the highest level of senior-friendly food.
[표 7] 고령친화식품의 식약처 인증제 기준(2019. 12. 12)[Table 7] Ministry of Food and Drug Safety certification system standards for senior-friendly foods (December 12, 2019)
한편, 영양성이 우수한 헴프씨드와 마를 첨가하여, 일반 쌀죽에서 부족한 영양성분, 특히 필수 아미노산을 포함하는 단백질, 필수 지방산(리놀레산, 알파-리놀렌산, 감마-리놀렌산 등)을 포함하는 기능성 지질, 미네랄, 비타민은 물론 불용성 식이섬유까지 포함하여 남녀노소, 노약자와 환자식으로도 유용하게 사용될 수 있음을 확인하였다(표 8). Meanwhile, by adding highly nutritious hemp seeds and yam, it contains nutrients lacking in regular rice porridge, especially proteins containing essential amino acids, functional lipids containing essential fatty acids (linoleic acid, alpha-linolenic acid, gamma-linolenic acid, etc.), minerals, and vitamins. It was confirmed that it can be usefully used as food for people of all ages, the elderly, and patients, including insoluble dietary fiber (Table 8).
[표 8] 멥쌀, 헴프씨드 및 마의 영양성분 비교[Table 8] Comparison of nutritional components of non-glutinous rice, hemp seed, and yam
실시예 3: 제조된 죽의 유용 성분 평가Example 3: Evaluation of useful ingredients of manufactured porridge
실시예 1에서 제조된 3종 죽 분말의 에탄올 추출물을 조제하였으며, 각각 추출물의 총 폴리페놀 함량, 총 플라보노이드 함량 및 총당 함량을 측정하였다. 이때, 에탄올 추출물은 죽 시료 중량에 대해 20배의 에탄올(95%, 덕산, 한국)를 가하고, 실온에서 8시간씩 2회 추출한 후 추출액을 모아 필터링한 후, 감압 농축하여 분말로 제조하였다. 각각의 추출효율 및 추출물의 성분 분석 결과는 표 8에 나타내었다. 총 폴리페놀 함량은 추출 검액 400μl에 50μl의 Folin-ciocalteau, 100μl의 Na2CO3 포화용액을 넣고 실온에서 1시간 방치한 후 725nm에서 흡광도를 측정하였다. 표준시약으로는 tannic acid를 사용하였다. 총 플라보노이드 함량은 각각의 시료를 18시간 메탄올 교반 추출하고, 여과한 추출 검액 400μl에 90% diethylene glycol 4ml를 첨가하고 다시 1 N NaOH 40μl를 넣고 37℃에서 1시간 반응 후 420nm에서 흡광도를 측정하였다. 표준시약으로는 rutin을 사용하였다. 총당은 phenol-sulfuric acid법을 이용하여 정량하였다. Ethanol extracts of the three types of porridge powder prepared in Example 1 were prepared, and the total polyphenol content, total flavonoid content, and total sugar content of each extract were measured. At this time, the ethanol extract was prepared by adding 20 times the weight of the porridge sample ethanol (95%, Deoksan, Korea), extracting it twice for 8 hours at room temperature, collecting the extracts, filtering them, and concentrating them under reduced pressure. The results of each extraction efficiency and component analysis of the extract are shown in Table 8. The total polyphenol content was measured by adding 50 μl of Folin-ciocalteau and 100 μl of Na 2 CO 3 saturated solution to 400 μl of the extraction sample solution, leaving it at room temperature for 1 hour, and measuring the absorbance at 725 nm. Tannic acid was used as a standard reagent. To determine the total flavonoid content, each sample was extracted with methanol stirring for 18 hours, 4ml of 90% diethylene glycol was added to 400μl of the filtered extraction solution, 40μl of 1 N NaOH was added again, and the absorbance was measured at 420nm after reacting for 1 hour at 37°C. Rutin was used as a standard reagent. Total sugars were quantified using the phenol-sulfuric acid method.
[표 9] 3종 죽 추출물의 추출효율 및 유용성분 분석[Table 9] Extraction efficiency and useful content analysis of three types of porridge extracts
표 9에 나타낸 바와 같이, 통상의 멥쌀죽의 경우 4.25%의 수율을 보인 반면, 해방풍 및 마를 첨가하여 제조한 죽의 경우 추출효율은 3.43%로 감소하였으며, 헴프씨드, 해방풍, 마를 첨가하여 제조된 죽의 우에는 4.02%를 나타내어 헴프씨드를 첨가한 경우 지용성 성분이 증가됨을 알 수 있었다. 총 폴리페놀 및 총 플라보노이드 함량 분석 결과, 통상의 멥쌀죽보다 해방풍, 마를 첨가한 경우 또는 헴프씨드, 방풍, 마를 첨가한 경우 총 폴리페놀 함량이 높게 나타나, 복원 죽 (2) 및 (3)에서 우수 생리활성을 기대할 수 있었다. 또한, 총당 함량 분석 결과 헴프씨드, 해방풍, 마를 첨가하여 제조된 죽의 경우 일반 멥쌀죽보다 2.24배 이상의 총당 함량이 나타나, 헴프씨드 유래의 생체 이용성이 높은 당류가 포함됨을 확인하였다. As shown in Table 9, the yield of regular non-glutinous rice porridge was 4.25%, while the extraction efficiency was reduced to 3.43% in the case of porridge prepared by adding hemp seeds, Haebangpung, and yam. In the case of porridge, it was 4.02%, showing that the fat-soluble component increased when hemp seeds were added. As a result of analyzing the total polyphenol and total flavonoid content, the total polyphenol content was higher when Haebangpung and yam were added or when hemp seed, bangpung, and yam were added compared to regular non-glutinous rice porridge, making it excellent for restoration porridge (2) and (3) Physiological activity could be expected. In addition, as a result of analyzing the total sugar content, porridge made by adding hemp seeds, Haebangpung, and yam showed a total sugar content of 2.24 times more than that of regular non-glutinous rice porridge, confirming that it contains highly bioavailable sugars derived from hemp seeds.
실시예 4: 제조된 죽의 항산화 활성 평가 Example 4: Evaluation of antioxidant activity of prepared porridge
실시예 3에서 제조된 3종 죽 분말의 에탄올 추출물의 항산화 활성을 평가하였으며, 추출물을 DMSO(dimethylsulfoxide)에 녹인 후 적당한 농도로 희석하여 DPPH(1,1-diphenyl-2-picryl hydrazyl) 음이온 라디칼 소거능, ABTS[2,2-azobis (3-ethylbenzo thiazoline-6-sulfonate)] 양이온 라디칼 소거능, nitrite 소거능 및 환원력 측정에 사용하였다. 먼저, DPPH 소거능의 경우 다양한 농도로 희석한 시료 20μl에, 99.5% 에탄올에 용해시킨 2x 10-4M DPPH 용액 380μl를 넣고 혼합하여 37℃에서 30분 동안 반응시킨 후, 516nm에서 microplate reader(Asys Hitech, Expert96, Asys Co., Austria)를 사용하여 흡광도를 측정하였다. DPPH radical 소거능은 시료첨가구와 비첨가구의 백분율로 표시하였다. ABTS 소거능의 경우 7mM ABTS(Sigma Co., USA) 5ml와 140mM potassium persulfate 88ml를 섞은 후 상온에서 16시간 빛을 차단하여 ABTS 양이온을 형성시켰으며, 이후 이 용액을 414nm에서 흡광도 값이 1.5가 되도록 에탄올로 희석하였다. 조제된 희석용액 190ml와 다양한 농도로 조제된 시료 10ml를 혼합한 후 상온에서 6분간 반응시킨 후 734nm에서 흡광도를 측정하고, 다음의 식에 의해 ABTS radical 소거능을 계산하였다. The antioxidant activity of the ethanol extract of the three types of porridge powder prepared in Example 3 was evaluated, and the extract was dissolved in DMSO (dimethylsulfoxide) and diluted to an appropriate concentration to determine the DPPH (1,1-diphenyl-2-picryl hydrazyl) anion radical scavenging ability. , ABTS[2,2-azobis (3-ethylbenzo thiazoline-6-sulfonate)] was used to measure cation radical scavenging ability, nitrite scavenging ability, and reducing power. First, in the case of DPPH scavenging ability, 380 μl of 2x 10 -4 M DPPH solution dissolved in 99.5% ethanol was added to 20 μl of sample diluted to various concentrations, mixed, reacted at 37°C for 30 minutes, and then measured using a microplate reader (Asys Hitech) at 516 nm. , Expert96, Asys Co., Austria) was used to measure absorbance. DPPH radical scavenging ability was expressed as a percentage of the sample added and the sample not added. In the case of ABTS scavenging ability, 5ml of 7mM ABTS (Sigma Co., USA) and 88ml of 140mM potassium persulfate were mixed and light was blocked for 16 hours at room temperature to form ABTS cations. This solution was then diluted with ethanol to obtain an absorbance value of 1.5 at 414nm. It was diluted with . After mixing 190 ml of the prepared diluted solution and 10 ml of samples prepared at various concentrations, reacted at room temperature for 6 minutes, absorbance was measured at 734 nm, and ABTS radical scavenging ability was calculated using the following equation.
ABTS radical 소거능 (%) = [(C-S)/C] x 100, ABTS radical scavenging ability (%) = [(C-S)/C] x 100,
C: 용매 대조구 DMSO 첨가시의 흡광도, S: 시료 첨가시의 흡광도.C: Absorbance when adding solvent control DMSO, S: Absorbance when adding sample.
한편, nitrite 소거능 측정의 경우, 아질산염 용액(1mM)에 시료용액을 가하고, 여기에 0.1N HCl을 가해 pH 1.2로 조정한 후, 37℃에서 1시간 반응시킨 후 Griess reagent(Sigma Co., USA)를 가하고 혼합하였다. 이후 15분간 실온에서 방치 후 520nm에서 흡광도를 측정하여 잔존 nitrite 양을 측정하였다. nitrite 소거능(%)는 다음의 식에 의해 계산하였다.Meanwhile, in the case of measuring nitrite scavenging ability, the sample solution was added to the nitrite solution (1mM), adjusted to pH 1.2 by adding 0.1N HCl, and reacted at 37°C for 1 hour using Griess reagent (Sigma Co., USA). was added and mixed. After leaving it at room temperature for 15 minutes, the absorbance was measured at 520 nm to measure the amount of remaining nitrite. The nitrite scavenging ability (%) was calculated using the following equation.
NSA (%) = [1-(A-C)/B] x100, NSA (%) = [1-(A-C)/B] x100,
A: 1mM nitrite 용액에 시료를 첨가하여 1시간 반응시킨 후의 흡광도,A: Absorbance after adding the sample to 1mM nitrite solution and reacting for 1 hour,
B: 1mM nitrite 용액의 흡광도, B: Absorbance of 1mM nitrite solution,
C: 추출물 시료의 흡광도.C: Absorbance of extract sample.
또한, 환원력 평가의 경우 Oyaizu 등의 방법을 변형(안선미 등, 2011. J. Life Sci. 21: 576-583)하여 측정하였다. 에탄올에 용해한 시료 2.5ml에 0.2M sodium phosphate buffer(pH 6.6) 2.5ml와 10% potassium ferricyanide 2.5ml를 첨가하고, 50℃에서 20분간 반응시킨 후, 10% trichloroacetic acid 2.5ml를 첨가하여 반응을 종료하고 4000rpm에서 10분간 원심분리하여 상등액을 회수하였다. 회수한 상등액은 증류수로 2배 희석한 후, 신선하게 조제된 0.1% ferric chloride 용액과 5:1(v/v) 비율로 혼합하고 700nm에서 흡광도를 측정하여 평가하였다. 상기의 항산화 실험에서 대조구로는 vitamin C(Sigma Co., USA)를 사용하였으며, 각각의 활성 평가는 각각 3회 반복한 실험의 평균과 편차로 표시하였다. In addition, in the case of reducing power evaluation, the method of Oyaizu et al. was modified (Ahn Seon-mi et al., 2011. J. Life Sci. 21: 576-583). To 2.5ml of sample dissolved in ethanol, 2.5ml of 0.2M sodium phosphate buffer (pH 6.6) and 2.5ml of 10% potassium ferricyanide were added, reacted at 50°C for 20 minutes, and then 2.5ml of 10% trichloroacetic acid was added to terminate the reaction. and centrifuged at 4000 rpm for 10 minutes to recover the supernatant. The recovered supernatant was diluted two-fold with distilled water, mixed with freshly prepared 0.1% ferric chloride solution in a 5:1 (v/v) ratio, and evaluated by measuring absorbance at 700 nm. In the above antioxidant experiment, vitamin C (Sigma Co., USA) was used as a control, and each activity evaluation was expressed as the average and deviation of the experiment repeated three times.
[표 10] 3종 죽 추출물의 항산화 활성[Table 10] Antioxidant activity of three types of porridge extracts
표 10에 나타낸 바와 같이, 통상의 일반죽 (1)보다 해방풍, 마, 헴프씨드를 첨가하여 제조된 죽 (3)의 경우 증가된 DPPH 음이온 소거능, ABTS 양이온 소거능 및 nitrite 소거능을 나타내었다. 그러나, 환원성의 경우 유의적인 증가는 나타나지 않았다. 따라서, 해방풍, 마, 헴프씨드를 첨가하여 제조된 죽 (3)의 경우 활성 양이온을 소거할 수 있는 (-)전하의 항산화 물질과 nitrite 제거물질을 다량 함유하고 있음을 확인하였다. As shown in Table 10, the porridge (3) prepared by adding Haebangpung, hemp, and hemp seeds showed increased DPPH anion scavenging ability, ABTS cation scavenging ability, and nitrite scavenging ability compared to the regular porridge (1). However, no significant increase was observed in reducibility. Therefore, it was confirmed that porridge (3) prepared by adding Haebangpung, hemp, and hemp seeds contained a large amount of (-)-charged antioxidant substances and nitrite removal substances that can scavenge active cations.
실시예 5: 제조된 죽의 항당뇨 활성 평가Example 5: Evaluation of antidiabetic activity of prepared porridge
실시예 3에서 제조된 3종 죽 분말의 에탄올 추출물의 항당뇨 활성을 평가하였으며, in-vitro α-glucosidase 저해 활성을 평가하여 표 11에 나타내었다. α-glucosidase 저해 활성은 pNPG(p-nitrophenol glucoside; Sigma Co., USA)를 이용하여 평가하였으며, 추출물 시료 2.5μl와 50mM Sodium acetate buffer(pH 5.6)로 희석한 α-glucosidase(0.25U/ml) 25μl를 혼합하여 37℃에서 10분간 1차 반응하고, 1mM pNPG 용액 25μl를 가하여 60℃에서 10분간 2차 반응하였다. 이후, 1M NaOH 25μl를 가하여 반응을 정지시키고, 405nm에서 흡광도를 측정하여 저해율을 계산하였다. The anti-diabetic activity of the ethanol extract of the three types of porridge powder prepared in Example 3 was evaluated, and the in-vitro α-glucosidase inhibitory activity was evaluated and is shown in Table 11. α-glucosidase inhibitory activity was evaluated using pNPG (p-nitrophenol glucoside; Sigma Co., USA), and α-glucosidase (0.25U/ml) diluted with 2.5μl of extract sample and 50mM sodium acetate buffer (pH 5.6). 25 μl was mixed and subjected to primary reaction at 37°C for 10 minutes, and 25 μl of 1mM pNPG solution was added to perform secondary reaction at 60°C for 10 minutes. Afterwards, 25 μl of 1M NaOH was added to stop the reaction, and the inhibition rate was calculated by measuring the absorbance at 405 nm.
저해율 (%) = [1-(시료 첨가구 효소활성/대조구 첨가구 효소활성)] x 100Inhibition rate (%) = [1-(enzyme activity when sample was added/enzyme activity when control was added)] x 100
[표 11] 3종 죽 추출물의 항당뇨 활성[Table 11] Antidiabetic activity of three types of porridge extracts
그 결과, 표 11에 나타낸 바와 같이, 통상의 일반죽 (1) 및 해방풍, 마를 첨가하여 제조한 죽 (2)보다 해방풍, 마, 헴프씨드를 첨가하여 제조된 죽 (3)의 경우 우수한 α-glucosidase 저해 활성을 나타내어 헴프씨드에 의한 항당뇨 활성을 나타내었다. 따라서, 상기의 해방풍, 마, 헴프씨드를 첨가하여 제조된 죽 (3)은 제2형 당뇨병의 예방 및 치료에 이용 가능함을 확인하였다.As a result, as shown in Table 11, superior α- It showed glucosidase inhibitory activity and showed anti-diabetic activity by hemp seeds. Therefore, it was confirmed that the porridge (3) prepared by adding Haebangpung, hemp, and hemp seeds can be used for the prevention and treatment of type 2 diabetes.
실시예 6: 제조된 죽의 항혈전 활성 평가Example 6: Evaluation of antithrombotic activity of prepared porridge
실시예 3에서 제조된 3종 죽 분말의 에탄올 추출물의 혈액응고 저해활성을 평가하여 그 결과를 표 12에 나타내었다. 이때, 혈액응고 저해활성 평가방법은 기존에 보고된 방법에 준해 평가하였으며(Sohn et al., 2004. Kor. J. Pharmacogn 35. 52-61; Kwon et al., 2004. J. Life Science, 14. 509-513; 류 등 2010. J. Life Science, 20. 922-928), 트롬빈 타임, 프로트롬빈 타임과 에이피티티 타임을 측정하였다. 혈장은 시판 control plasma(MD Pacific Technology Co., Ltd, Huayuan Industrial Area, China)를 사용하였으며 트롬빈 타임, 프로트롬빈 타임과 에이피티티 측정법은 다음과 같은 과정으로 수행되었다.The blood coagulation inhibitory activity of the ethanol extract of the three types of porridge powder prepared in Example 3 was evaluated, and the results are shown in Table 12. At this time, the blood coagulation inhibitory activity evaluation method was evaluated according to the previously reported method (Sohn et al., 2004. Kor. J. Pharmacogn 35. 52-61; Kwon et al., 2004. J. Life Science, 14 509-513; Ryu et al. 2010. J. Life Science, 20. 922-928), thrombin time, prothrombin time and aptitude time were measured. As plasma, commercially available control plasma (MD Pacific Technology Co., Ltd, Huayuan Industrial Area, China) was used, and thrombin time, prothrombin time, and aptitude measurement methods were performed as follows.
트롬빈 타임(Thrombin Time)Thrombin Time
37℃에서 0.5U 트롬빈(Sigma Co., USA) 50μl와 20 mM CaCl2 50μl, 다양한 농도의 시료 추출액 10μl를 Amelung coagulometer KC-1A(Japan)의 튜브에 혼합하여 2분간 반응시킨 후, 혈장 100μl를 첨가한 후 혈장이 응고될 때까지의 시간을 측정하였다. 대조로는 아스피린(Sigma Co., USA)을 사용하였으며, 용매 대조구로는 시료 대신 DMSO를 사용하였다. DMSO의 경우 32.1초의 응고시간을 나타내었다. 트롬빈 저해 효과는 3회 이상 반복한 실험의 평균치로 나타내었으며, 트롬빈 저해활성은 시료 첨가시의 응고시간을 용매 대조구의 응고시간으로 나눈 값으로 나타내었다.At 37°C, 50 μl of 0.5U thrombin (Sigma Co., USA), 50 μl of 20 mM CaCl 2 , and 10 μl of sample extracts of various concentrations were mixed in a tube of an Amelung coagulometer KC-1A (Japan) and reacted for 2 minutes, and then 100 μl of plasma was added. The time until the plasma coagulated after addition was measured. Aspirin (Sigma Co., USA) was used as a control, and DMSO was used instead of the sample as a solvent control. In the case of DMSO, the coagulation time was 32.1 seconds. The thrombin inhibitory effect was expressed as the average value of experiments repeated three or more times, and the thrombin inhibitory activity was expressed as the coagulation time when adding the sample divided by the coagulation time of the solvent control.
프로트롬빈 타임(prothrombin time)prothrombin time
표준혈장(MD Pacific Co., China) 70μl와 다양한 농도의 시료액 10μl를 Amelung coagulometer KC-1A(Japan)의 튜브에 첨가하여 37℃에서 3분간 가온 후, 130μl의 PT reagent를 첨가하고 혈장이 응고될 때까지의 시간을 3회 반복한 실험의 평균치로 나타내었다. 대조로는 아스피린(Sigma Co., USA)을 사용하였으며, 용매 대조구로는 시료 대신 DMSO를 사용하였다. DMSO의 경우 18.1초의 응고시간을 나타내었다. 프로트롬빈 저해활성은 시료 첨가시의 응고시간을 용매 대조구의 응고시간으로 나눈 값으로 나타내었다.70 μl of standard plasma (MD Pacific Co., China) and 10 μl of sample solution of various concentrations were added to the tube of Amelung coagulometer KC-1A (Japan) and heated at 37°C for 3 minutes, then 130 μl of PT reagent was added and the plasma was coagulated. The time until this was achieved was expressed as the average value of the experiment repeated three times. Aspirin (Sigma Co., USA) was used as a control, and DMSO was used instead of the sample as a solvent control. In the case of DMSO, the coagulation time was 18.1 seconds. Prothrombin inhibitory activity was expressed as the coagulation time upon sample addition divided by the coagulation time of the solvent control.
aPTT(activated Partial Thromboplastin Time) activated Partial Thromboplastin Time (aPTT)
혈장 100μl와 다양한 농도의 시료 추출액 10μl를 Amelung coagulometer KC-1A(Japan)의 튜브에 첨가하여 37℃에서 3분간 가온한 후, 50μl의 aPTT reagent(Sigma, ALEXINTM)를 첨가하고 다시 37℃에서 3분간 배양하였다. 이후, 50μl CaCl2(35mM)을 첨가한 후 혈장이 응고될 때까지의 시간을 측정하였다. 용매 대조구로는 시료 대신 DMSO를 사용하였으며, 이 경우 55.1초의 응고시간을 나타내었다. aPTT의 결과는 3회 반복한 실험의 평균치로 나타내었으며, 혈액응고인자 저해활성은 시료 첨가시의 aPTT 시간을 용매 대조구의 aPTT 시간으로 나눈 값으로 나타내었다.100 μl of plasma and 10 μl of sample extracts of various concentrations were added to the tube of Amelung coagulometer KC-1A (Japan) and heated at 37°C for 3 minutes, then 50 μl of aPTT reagent (Sigma, ALEXIN TM ) was added and incubated again at 37°C for 3 minutes. It was incubated for a minute. Afterwards, 50μl CaCl 2 (35mM) was added and the time until the plasma coagulated was measured. As a solvent control, DMSO was used instead of the sample, and in this case, the coagulation time was 55.1 seconds. The results of aPTT were expressed as the average value of three repeated experiments, and the blood coagulation factor inhibitory activity was expressed as the aPTT time at the time of sample addition divided by the aPTT time of the solvent control.
[표 12] 3종 죽 추출물의 혈액응고 저해활성[Table 12] Blood coagulation inhibitory activity of three types of porridge extracts
그 결과, 표 12에 나타낸 바와 같이 해방풍, 마, 헴프씨드를 첨가하여 제조된 죽 (3)의 경우 에탄올 추출물은 5mg/ml 농도에서 아스피린(1.5 mg/ml)보다는 미약한 혈액응고 저해활성을 나타내었으나, 통상의 일반죽 (1)보다는 우수한 프로트롬빈 저해, 혈액응고인자 저해를 나타내었다. 이러한 결과는 해방풍, 마, 헴프씨드를 첨가하여 제조된 죽 (3)은 내인성 혈전 생성 및 외인성 혈전 생성을 효율적으로 저해하여 혈전성 심혈관계, 뇌혈관계 질환의 예방 및 개선에 기여하리라 판단된다. As a result, as shown in Table 12, in the case of porridge (3) prepared by adding Haebangpung, hemp, and hemp seeds, the ethanol extract showed weaker blood coagulation inhibitory activity at a concentration of 5 mg/ml than aspirin (1.5 mg/ml). However, it showed better prothrombin inhibition and blood coagulation factor inhibition than regular porridge (1). These results indicate that porridge (3) prepared by adding Haebangpung, hemp, and hemp seeds is believed to contribute to the prevention and improvement of thrombotic cardiovascular and cerebrovascular diseases by efficiently inhibiting endogenous and exogenous thrombus formation.
실시예 7: 제조된 죽의 인간 적혈구 용혈활성 평가Example 7: Evaluation of human red blood cell hemolytic activity of prepared porridge
실험에 사용된 모든 성분이 식품원재료로 등록되어 안전성이 확보되어 있으나, 가열제조 및 동결건조 중에 나타날 수 있는 식품 성분의 급성독성 가능성을 평가하기 위해 실시예 3에서 제조된 3종 죽 분말의 에탄올 추출물을 대상으로 인간 적혈구 용혈 활성을 평가하였다(표 13). 이때, 용혈 활성은 기존의 보고(손호용, 2014년 ㆍKorean J. Microbiol. Biotechnol. 42: 285-292)에 준해 평가하였으며, 간단하게는 PBS로 3회 수세한 인간 적혈구 100μl를 96-well microplate에 가하고 다양한 농도의 시료용액 100μl를 가한 다음 37℃에서 30분간 반응시켰으며, 이후, 반응액을 10분간 원심분리(1,500rpm)하여 상등액 100μl를 새로운 microtiter plate로 옮긴 후 용혈에 따른 헤모글로빈 유출 정도를 414nm에서 측정하였다. 시료의 용매 대조구로는 DMSO(2%)를 사용하였으며, 적혈구 용혈을 위한 실험 대조구로는 Triton X-100(1mg/ml)를 사용하였다. 용혈 활성은 다음의 수식을 이용하여 계산하였다.Although all ingredients used in the experiment are registered as food raw materials and ensure safety, in order to evaluate the possibility of acute toxicity of food ingredients that may appear during heat production and freeze-drying, ethanol extracts of the three types of porridge powder prepared in Example 3 were used. The hemolytic activity of human red blood cells was evaluated (Table 13). At this time, hemolytic activity was evaluated according to an existing report (Ho-yong Son, 2014, Korean J. Microbiol. Biotechnol. 42: 285-292), and simply, 100 μl of human red blood cells washed three times with PBS were placed in a 96-well microplate. 100 μl of sample solutions of various concentrations were added and reacted at 37°C for 30 minutes. Afterwards, the reaction solution was centrifuged (1,500 rpm) for 10 minutes, 100 μl of the supernatant was transferred to a new microtiter plate, and the degree of hemoglobin leakage due to hemolysis was measured at 414 nm. It was measured in . DMSO (2%) was used as a solvent control for the sample, and Triton X-100 (1 mg/ml) was used as an experimental control for red blood cell hemolysis. Hemolytic activity was calculated using the following formula.
[표 13] 3종 죽 추출물의 인간 적혈구 용혈 활성[Table 13] Human red blood cell hemolytic activity of three types of porridge extracts
표 13에 나타낸 바와 같이, 대조구로 사용된 DMSO와 물은 용혈 활성이 없었으며, triton X-100은 1mg/ml 농도에서 적혈구를 100% 용혈시킴을 확인하였다. 또한, 항암제, 항진균제로 사용되고 있는 amphotericin B의 경우 0.00625mg/ml 농도에서 50%의 적혈구를 용혈시킴을 확인하였다. 본 발명의 3종 죽 추출물은 1mg/ml 농도까지 전혀 적혈구 용혈현상이 나타나지 않아 급성독성 및 적혈구 용혈 활성은 없음을 확인하였다.As shown in Table 13, DMSO and water used as controls had no hemolytic activity, and triton In addition, in the case of amphotericin B, which is used as an anticancer and antifungal agent, it was confirmed that 50% of red blood cells were hemolyzed at a concentration of 0.00625mg/ml. It was confirmed that the three types of porridge extracts of the present invention showed no red blood cell hemolysis at all up to a concentration of 1 mg/ml, showing no acute toxicity and no red blood cell hemolytic activity.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210050150A KR102660060B1 (en) | 2021-04-16 | 2021-04-16 | Functional porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, Glehnia littoralis and yam |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210050150A KR102660060B1 (en) | 2021-04-16 | 2021-04-16 | Functional porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, Glehnia littoralis and yam |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220143525A KR20220143525A (en) | 2022-10-25 |
KR102660060B1 true KR102660060B1 (en) | 2024-04-24 |
Family
ID=83804083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210050150A KR102660060B1 (en) | 2021-04-16 | 2021-04-16 | Functional porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, Glehnia littoralis and yam |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102660060B1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100812759B1 (en) | 2006-12-12 | 2008-03-12 | 충청남도 당진군(농업기술센터) | Method for manufacturing hot cereal including hempseed |
KR20090132258A (en) * | 2008-06-20 | 2009-12-30 | 목포대학교산학협력단 | Method for producing instant lyophilized porridge |
KR20130133310A (en) * | 2012-01-09 | 2013-12-09 | 사단법인 서동마 향토산업 사업단 | Manufacturing method for a gruel using dioscorea batatas decne |
KR101789183B1 (en) * | 2014-11-20 | 2017-10-23 | 농업회사법인 달맞이식품 유한회사 | Method for Manufacturing Noodle Containing Glehnia littoralis |
KR20170128028A (en) * | 2016-05-13 | 2017-11-22 | 박선희 | Method for preparing functional noodle containing hempseed and functional noodle prepared therefrom |
KR101886851B1 (en) | 2016-12-21 | 2018-08-09 | 농업회사법인편죽 주식회사 | A process for the preparation of juk comprising siler divaricata and blood arkshell and the juk prepared therefrom |
-
2021
- 2021-04-16 KR KR1020210050150A patent/KR102660060B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20220143525A (en) | 2022-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004159637A (en) | Dietary composition | |
Nabeshima et al. | Tubers and roots as a source of prebiotic fibers | |
Chen et al. | Traditional food, modern food and nutritional value of Sea buckthorn (Hippophae rhamnoides L.): A review | |
KR100659015B1 (en) | The method for manufacturing of functional health food | |
KR102305931B1 (en) | A food composition for improving circulation of blood and increasing functions of immune comprising natural extracts | |
KR20190123921A (en) | A method for preparing functional pills comprising extracts of natural materials | |
KR102115622B1 (en) | Pharmaceutical composition comprising the fermentation extract of medicinal or edible natural products as an effective component for prevention or treatment of thrombosis and health functional food comprising the same | |
KR102168192B1 (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
KR102660060B1 (en) | Functional porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, Glehnia littoralis and yam | |
KR101768612B1 (en) | Food composition for improving liver function and method of health tea using thereof | |
KR20200053016A (en) | Pharnaceutical composition for prevention or treatment of diabetes comprising the mixed extract of vegetable natural products having the effect on removal of swelling and health functional food for prevention or improvement of diabetes comprising the same | |
KR100337472B1 (en) | Health food beverage composition containing prickly pear extract | |
KR102672335B1 (en) | Functional red bean porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, beta vulgaris, walnut and almond | |
KR101468653B1 (en) | Manufacturing method of dried functional snack made of tomato | |
KR101953576B1 (en) | Functional beverage for anticancer and process for preparing the same | |
KR101947013B1 (en) | Pudding comprising aronia, Cudrania tricuspidata and blueberry extract and preparation method thereof | |
KR100880817B1 (en) | The hot sauce containing medicinal herbs | |
Chaudhary et al. | Studies on development of syrup from mango (Mangifera indica L.) pulp and aloe vera (Aloe barbadensis Miller.) gel blend | |
KR102311266B1 (en) | A composition for improving circulation of blood, antiinflammation, activating and generating cell, and increasing functions of immune and internal organs comprising arrowroot juice and plum concentrates | |
KR102365198B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume, Polygonum multiflorum Thunberg and mountain ginseng | |
KR102262551B1 (en) | Manufacturing Method of Soup using Chicken Breast and Soup Composition using Chicken Breast | |
KR102450640B1 (en) | Manufacturing method of beet juice with added functional ingredients | |
KR102653686B1 (en) | Food composition for alleviating swelling through detoxification and detoxification effects | |
KR102632842B1 (en) | Herbal diet functional food with rosehip extract | |
KR102155513B1 (en) | Method for producing sunsik adding wild vegetables powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |